Citation, DOI, disclosures and article data
At the time the article was created Maciej Debowski had no recorded disclosures.View Maciej Debowski's current disclosures
Radiotherapy, also known as radiation therapy, is a common oncologic treatment modality utilizing ionizing radiation to control or eliminate malignant cells. Radiotherapy plays a role in primary curative treatment (eg. head and neck cancer), adjuvant therapy (e.g. reducing recurrence rate after local breast cancer surgery) and palliation of cancer symptoms (e.g. reducing pain from bone metastases). Radiotherapy may be used alone, or synergistically with chemotherapy or immunotherapy, e.g. "chemoradiotherapy" etc.
Radiotherapy is also, less commonly, used to treat non-malignant disease, e.g. Graves thyroiditis, keloid scarring, etc.
Radiotherapy is commonly abbreviated to RT, RTx, DXT (deep x-ray therapy) and XRT (x-ray therapy) in medical records.
Radiotherapy is customarily divided into three main categories:
external beam radiotherapy (EBRT) where a medical linear accelerator (linac) directs ionizing radiation at the tumor from outside the body
- conventional radiation therapy
- three-dimensional conformal radiation therapy (3D-CRT)
- intensity-modulated radiation therapy (IMRT)
- stereotactic radiosurgery
- electron therapy
- particle (hadronic) therapy
- sealed source radiotherapy (brachytherapy) where a radiation source(s) is placed inside or next to the tissue requiring treatment
- unsealed source radiotherapy (systemic radioisotope therapy) where a radioisotope is delivered through infusion (e.g. Lu-177-DOTATATE for neuroendocrine tumors) or ingestion (e.g. I-131 for thyroid cancer)